Alembic Ltd Share Price – NSE /  BSE

Realty, Small Cap

Revenue from operations margianlly shed 0.38% year on year (YoY) to Rs 60.04 crore in the quarter ended 31 March 2026.

Profit before tax (PBT) stood at Rs 18.44 crore in Q4 FY26, down 31.50% from Rs 26.92 crore recorded in the same quarter last year.

Total expenses jumped 20.42% YoY to Rs 43.74 crore in Q4 FY26. The cost of materials consumed stood at Rs 4.04 crore (up 110.41% YoY), while employee benefit expenses rose 80.61% YoY to Rs 11.74 crore during the period under review.

The company recommended a dividend of Rs 2.40 per equity share of face value Rs 2 each (120%) for FY26.

Alembic is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

Powered by Capital Market - Live News

Alembic announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the final dividend of Rs 2.4 per equity Share (i.e. 120%) , subject to the approval of the shareholders.

Net profit of Alembic declined 1.93% to Rs 67.13 crore in the quarter ended March 2026 as against Rs 68.45 crore during the previous quarter ended March 2025. Sales declined 0.38% to Rs 60.04 crore in the quarter ended March 2026 as against Rs 60.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 2.16% to Rs 317.38 crore in the year ended March 2026 as against Rs 310.68 crore during the previous year ended March 2025. Sales rose 8.16% to Rs 239.99 crore in the year ended March 2026 as against Rs 221.89 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Alembic will hold a meeting of the Board of Directors of the Company on 19 May 2026.